Evidence map›Paper›PMID 33236619›Full record

ArticleJournal of biomedical optics2020

Implantable sensor for local Cherenkov-excited luminescence imaging of tumor pO2 during radiotherapy.

Xu Cao, Jason R Gunn, Srinivasa Rao Allu, Petr Bruza, Shudong Jiang, Sergei A Vinogradov, Brian W Pogue

Open access · goldAbstract read
In one paragraph

Article in Journal of biomedical optics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Xu CaoDartmouth College, Thayer School of Engineering, Hanover, New Hampshire, United States.
Jason R GunnDartmouth College, Thayer School of Engineering, Hanover, New Hampshire, United States.
Srinivasa Rao AlluUniversity of Pennsylvania, Perelman School of Medicine, Department of Biochemistry and Biophysics,, United States.
Petr BruzaDartmouth College, Thayer School of Engineering, Hanover, New Hampshire, United States.
Shudong JiangDartmouth College, Thayer School of Engineering, Hanover, New Hampshire, United States.
Sergei A VinogradovUniversity of Pennsylvania, Perelman School of Medicine, Department of Biochemistry and Biophysics,, United States.
Brian W PogueDartmouth College, Thayer School of Engineering, Hanover, New Hampshire, United States.
Dartmouth College · USUniversity of Pennsylvania · USCotton (United States) · USDartmouth–Hitchcock Medical Center · USXidian University · CN

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Steven D Leach · 1985 to 2026
$91.3M
Cerenkov excited luminescence sheet imaging (CELSI)R01EB024498 · NIBIB · DARTMOUTH COLLEGE · PI POGUE, BRIAN WILLIAM · 2017 to 2020
$2.2M
Oxygen imaging by phosphorescence quenchingU24EB028941 · NIBIB · UNIVERSITY OF PENNSYLVANIA · PI VINOGRADOV, SERGEI · 2019 to 2023
$1.6M
A molecular probe for high-resolution dual imaging of temperature and oxygen in vivoR21EB027397 · NIBIB · UNIVERSITY OF PENNSYLVANIA · PI VINOGRADOV, SERGEI · 2018 to 2019
$464k
NCI NIH HHS P30 CA023108NIBIB NIH HHS R01 EB024498NIBIB NIH HHS R21 EB027397NIBIB NIH HHS U24 EB028941
6 · The paper itself

Abstract

significanceThe necessity to use exogenous probes for optical oxygen measurements in radiotherapy poses challenges for clinical applications. Options for implantable probe biotechnology need to be improved to alleviate toxicity concerns in human use and facilitate translation to clinical trial use.

aimTo develop an implantable oxygen sensor containing a phosphorescent oxygen probe such that the overall administered dose of the probe would be below the Federal Drug Administration (FDA)-prescribed microdose level, and the sensor would provide local high-intensity signal for longitudinal measurements of tissue pO2. APPROACH: PtG4, an oxygen quenched dendritic molecule, was mixed into an agarose matrix at 100  μM concentration, allowing for local injection into tumors at the total dose of 10 nmol per animal, forming a gel at the site of injection. Cherenkov-excited luminescence imaging (CELI) was used to acquire the phosphorescence and provide intratumoral pO2.

resultsAlthough PtG4 does not form covalent bonds with agarose and gradually leaches out into the surrounding tissue, its retention time within the gel was sufficiently long to demonstrate the capability to measure intratumoral pO2 with the implantable gel sensors. The sensor's performance was first evaluated in vitro in tissue simulation phantoms, and then the sensor was used to measure changes in oxygen in MDA-MB-231 tumors during hypofractionated radiotherapy.

conclusionsOur study demonstrates that implantable oxygen sensors in combination with CELI present a promising approach for quantifying oxygen changes during the course of radiation therapy and thus for evaluating the tumor response to radiation. By improving the design of the gel-probe composition in order to prevent leaching of the probe into the tissue, biosensors can be created that should allow longitudinal oxygen measurements in tumors by means of CELI while using FDA-compliant microdose levels of the probe and thus lowering toxicity concerns.

Indexed as

LuminescenceNeoplasmsAnimalsHumansOptical ImagingOxygenPhantoms, ImagingOxygenCherenkovhypoxiaimplantable probeoxygen imagingradiotherapy

Identifiers

PMID33236619
PMCPMC7685386
OpenAlexW3106779974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.